Phytimpact

Phytimpact is an e-biotech, a unique concept offering effective and reliable health alternatives for people with type II diabetes. In 2030, four billion people will be diagnosed with diabetes worldwide. Thanks to our business model, which combines a Web marketing strategy (online store) for rapid sales with an R&D strategy that is always on the lookout for innovative technologies and ideas, Phytimpact is constantly adding to its online store, the natural global reference for people with type II diabetes (www.natural-diabetes-store.com). Our diverse range of products listed from around the world allows us to offer products tailored to the needs of diabetics in the fields of nutrition, natural health products (NPN) developed by private brands (American and French alliances), as well as by our own R&D department. Phytimpact plans to focus future efforts on the discovery of innovative formulations and new patented active ingredients to meet the needs of its customers. www.phytimpact.com

This post is also available in: French

  • Our Sponsors

     

    Nos commanditaires : EY, CRIM, Fonds des Médias, CRIM, CDEC Centre-Nord, BDSL avocats, Teralys Capital, Burns & Levinson LLP,  Fonds de Solidarité FTQ, Deveaux Brault Munger, Valeo, Air Imex
  • Subscribe to our newsletter (in French)